Surprising
A probiotic improved quality of life in children with drug-resistant epilepsy — but the trial was tiny and the population highly specific.
This small, 6‑month trial suggests Lactobacillus acidophilus may help children whose epilepsy hasn’t responded to standard drugs, but with only 60 participants and no replication yet, the finding is intriguing rather than actionable for the general public.
In a double‑blind trial, 60 children with drug‑resistant epilepsy who took a daily Lactobacillus acidophilus probiotic alongside their usual medication showed a statistically significant improvement in quality‑of‑life scores compared to placebo. The same study also found fewer seizures and lower levels of inflammatory markers like HMGB1 and IL‑1β. Because this is one of the first studies to look at this pairing, the results need confirmation in larger, more diverse groups before drawing broad conclusions.
Where this fits in the evidence
This is among the first studies we've indexed on Lactobacillus acidophilus for Improved Quality of Life — treat it as an early signal until more research accumulates.
The study
- Randomized Controlled Trial (RCT)
- n = 60
- 2026-03-01
- Pharmacotherapy
- PubMed: 41693686
- DOI: 10.1002/phar.70117
- Full study breakdown →
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.